TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION DIN 02564475
Health Canada record
| Active ingredient(s) | DICLOFENAC POTASSIUM 50 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AB05 DICLOFENAC |
| Original market date | 29-May-2026 |
| Current status date | 29-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DICLOFENAC POTASSIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02567768 | APO-DICLOFENAC POWDER | APOTEX INC | Powder For Solution | DICLOFENAC POTASSIUM 50 MG | Approved |
| 02381680 | CAMBIA | ARALEZ PHARMACEUTICALS CANADA INC | Powder For Solution | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 02563290 | JAMP DICLOFENAC FOR SOLUTION | JAMP PHARMA CORPORATION | Powder For Solution | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 02560631 | RIVA-DICLOFENAC | LABORATOIRE RIVA INC. | Powder For Solution | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 02261774 | SANDOZ DICLOFENAC RAPIDE | SANDOZ CANADA INCORPORATED | Tablet | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 02239355 | TEVA-DICLOFENAC-K | TEVA CANADA LIMITED | Tablet | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 00881635 | VOLTAREN RAPIDE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | DICLOFENAC POTASSIUM 50 MG | Marketed |
| 02243433 | APO-DICLO RAPIDE 50 MG TABLETS | APOTEX INC | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Post Market |
| 02351684 | DICLOFENAC K | SANIS HEALTH INC | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Post Market |
| 02346281 | NTP-DICLOFENAC POTASSIUM | TEVA CANADA LIMITED | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Pre Market |
| 02336413 | NU-DICLO RAPIDE | NU-PHARM INC | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled (Unreturned Annual) |
| 02239753 | PMS-DICLOFENAC K | PHARMASCIENCE INC | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Post Market |
| 02311461 | PRO-DICLO RAPIDE - 50 | PRO DOC LIMITEE | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Post Market |
| 02240728 | RIVA-DICLOFENAC-K 50MG TABLETS | LABORATOIRE RIVA INC. | Tablet | DICLOFENAC POTASSIUM 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37334 | 2026-04-15 | Abbreviated New Drug Submission (ANDS) |
International API supply for DICLOFENAC POTASSIUM
4 valid EDQM Certificates of Suitability from 4 holders. 7 active FDA Drug Master Files.
Request a quote for TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION